Advertisement
Screener

Verrica Pharmaceuticals Inc. (VRCA) Net Margin

Verrica Pharmaceuticals Inc. (VRCA) Net Margin

  • 2026-06-30: Net Margin -224.38%.
  • 2026-03-31: Net Margin -192.75%.
  • 2025-12-31: Net Margin -158.56%.
  • 2025-09-30: Net Margin -1.91%.

Complete source-backed net margin history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-224.38%
2026-03-31-192.75%
2025-12-31-158.56%
2025-09-30-1.91%
2025-06-301.61%
2025-03-31-283.28%
2024-12-31-4709.88%
2024-09-301283.55%
2024-06-30-331.97%
2024-03-31-531.39%
2023-12-31-1238.13%
2023-09-30-850.26%
2023-06-30-6038.46%
2023-03-31-17808.11%
2022-12-31-8723.53%
2022-09-301.00%
2022-06-30-4751.40%
2022-03-31-1965.20%
2021-03-31-7.80%

Annual Net Margin

DateNet Margin
2025-12-31-50.27%
2024-12-31-1012.15%
2023-12-31-1307.47%
2022-12-31-271.11%
2021-12-31-292.33%

Similar stocks

Stock NameCountryMarket CapPE Ratio
OS Therapies Inc (OSTX)United States$0.076B-2.17
iBio, Inc. (IBIO)United States$0.077B-2.94
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40